Nanomedicine and nanotoxicology: the pros and cons for neurodegeneration and brain cancer
MetadataShow full item record
Current strategies for brain diseases are mostly symptomatic and noncurative. Nanotechnology has the potential to facilitate the transport of drugs across the blood-brain barrier and to enhance their pharmacokinetic profile. However, to reach clinical application, an understanding of nanoneurotoxicity in terms of oxidative stress and inflammation is required. Emerging evidence has also shown that nanoparticles have the ability to alter autophagy, which can induce inflammation and oxidative stress, or vice versa. These effects may increase neurodegenerative processes damage, but on the other hand, they may have benefits for brain cancer therapies. In this review, we emphasize how nanomaterials may induce neurotoxic effects focusing on neurodegeneration, and how these effects could be exploited toward brain cancer treatment.
Artículo de publicación ISISin acceso a texto completo
DOI: DOI: 10.2217/nnm.15.189
Quote ItemNaomedicine Volumen: 11 Número: 2 (2016)
The following license files are associated with this item: